Physician profile
David Irwin Jones
NPI 1366440596
$8,623.32
in general payments reported to CMS, 2019-2025
41 companies · $51.73 in 2025
The $51.73 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,575 · 2020: $466 · 2021: $1,095 · 2022: $1,785 · 2023: $1,601 · 2024: $1,050 · 2025: $51.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,603 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,602.76 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,322.43 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Ethicon INC. | $1,238.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,147.59 | 2019-2024 | Tezspire, Airsupra, Bevespi Aerosphere |
| Mylan Specialty L.P. | $529.44 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $495.23 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $467.72 | 2019-2024 | Ofev |
| Harmony Biosciences LLC | $436.91 | 2020-2024 | Wakix |
| Intuitive Surgical, INC. | $434.05 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $425.31 | 2019-2024 | Opsumit, Uptravi |
| Gilead Sciences, INC. | $227.92 | 2019-2023 | |
| Baxter Healthcare | $162.44 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Sunovion Pharmaceuticals INC. | $147.24 | 2019 | |
| Inspire Medical Systems, INC. | $140.92 | 2024 | Inspire |
| United Therapeutics Corporation | $131.01 | 2019-2024 | Tyvaso |
| Pfizer INC. | $130.81 | 2019-2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $121.64 | 2023-2024 | Dupixent |
| Axsome Therapeutics, INC. | $114.54 | 2023-2024 | Sunosi |
| Genzyme Corporation | $105.99 | 2022-2024 | |
| Resmed Corp | $86.36 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.16 | 2022-2023 | Xifaxan |
| Advanced Respiratory, INC | $77.82 | 2019-2020 | |
| Inogen, INC. | $77.55 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $76.24 | 2023-2024 | Purified Cortrophin Gel |
| Csl Behring | $60.79 | 2019-2024 | Privigen, Hizentra |
| Genentech USA, INC. | $47.27 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $39.19 | 2019 | |
| Abbvie INC. | $34.91 | 2023-2024 | |
| Grifols USA, LLC | $33.33 | 2024 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $32.06 | 2019 | |
| Ardelyx, INC. | $24.79 | 2025 | Ibsrela |
| Sanofi-Aventis U.S. LLC | $22.35 | 2020 | |
| Mallinckrodt Hospital Products INC. | $19.19 | 2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $17.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.22 | 2024 | Glassia |
| Electromed, INC. | $16.87 | 2019 | |
| Hospira, INC. | $16.86 | 2024 | |
| Fisher & Paykel Healthcare INC | $15.43 | 2023 | Fisher & Paykel Healthcare |
| Cmp Pharma, INC. | $15.15 | 2023 | Tadliq |
| Allergan, INC. | $12.14 | 2020 | |
| Philips North America LLC | $11.41 | 2019 | |
| Circassia INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.